TERN icon

Terns Pharmaceuticals
TERN

Overview Fund Trends Analyst Outlook Journalist POV

42 hedge funds and large institutions have $26.4M invested in Terns Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

47% less capital invested

Capital invested by funds: $50M → $26.4M (-$23.6M)

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.13M
2
+$1.74M
3
+$995K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$936K
5
Millennium Management
Millennium Management
New York
+$469K

Top Sellers

1
-$6.97M
2
-$5.5M
3
-$1.46M
4
AC
Antara Capital
New York
-$497K
5
State Street
State Street
Massachusetts
-$354K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$46K
27
$45K
28
$41K
29
$36K
30
$33K
31
$31K
32
$28K
33
$26K
34
$9.4K
35
$6K
36
$2K
37
$1K
38
$801
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2